標(biāo)題: Titlebook: Biological and Clinical Landscape of Meningiomas; Gelareh Zadeh,Roland Goldbrunner,Farshad Nassiri Book 2023 The Editor(s) (if applicable) [打印本頁] 作者: Braggart 時間: 2025-3-21 16:46
書目名稱Biological and Clinical Landscape of Meningiomas影響因子(影響力)
書目名稱Biological and Clinical Landscape of Meningiomas影響因子(影響力)學(xué)科排名
書目名稱Biological and Clinical Landscape of Meningiomas網(wǎng)絡(luò)公開度
書目名稱Biological and Clinical Landscape of Meningiomas網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biological and Clinical Landscape of Meningiomas被引頻次
書目名稱Biological and Clinical Landscape of Meningiomas被引頻次學(xué)科排名
書目名稱Biological and Clinical Landscape of Meningiomas年度引用
書目名稱Biological and Clinical Landscape of Meningiomas年度引用學(xué)科排名
書目名稱Biological and Clinical Landscape of Meningiomas讀者反饋
書目名稱Biological and Clinical Landscape of Meningiomas讀者反饋學(xué)科排名
作者: violate 時間: 2025-3-21 22:20
Imaging Characteristics of Meningiomas,es are frequently used in nearly all clinical settings where meningiomas are treated for the routine diagnosis and follow-up of these tumors, advances in neuroimaging have provided novel opportunities for prognostication and treatment planning (including both surgical planning and radiotherapy plann作者: 勛章 時間: 2025-3-22 01:29 作者: 龍卷風(fēng) 時間: 2025-3-22 05:58 作者: 呼吸 時間: 2025-3-22 11:39 作者: 腐敗 時間: 2025-3-22 16:50
Surgical Therapy of Non-Skull Base Meningiomas,perated on are non-skull base tumors located in the parasagittal/parafalcine region and convexity, and more rarely along the tentorium, and in an intraventricular?location. These tumors present their own unique set of challenges given their unique anatomy and tend to be more biologically aggressive 作者: Judicious 時間: 2025-3-22 21:06 作者: 充氣女 時間: 2025-3-22 22:34 作者: 催眠 時間: 2025-3-23 03:41
Advances in Central Nervous System Tumor Classification,r, the molecular era of medicine has resulted in new diagnostic paradigms anchored in the intrinsic biology of disease. The 2021 World Health Organization (WHO) reformulated the classification of CNS tumors to incorporate molecular parameters, in addition to histology, to define many tumor types. A 作者: 前面 時間: 2025-3-23 06:42
Genomic Landscape of Meningiomas,pter we will discuss the early cytogenetic?and mutational changes uncovered in meningiomas, from the discovery of the loss of chromosome 22q and the neurofibromatosis-2 (.) gene to other non-. driver mutations (., etc.) discovered using?next generation sequencing. We discuss each of these alteration作者: 有惡意 時間: 2025-3-23 11:47 作者: BLANK 時間: 2025-3-23 16:51 作者: 過份好問 時間: 2025-3-23 18:01
Immune Profiling of Meningiomas,sive and refractory to the current standards of care treatment?modalities. Coinciding with this has been increasing recognition of the important?that the immune system plays in mediating tumor growth and response to therapy. To address this point, immunotherapy has been leveraged for several other c作者: FLAG 時間: 2025-3-24 00:39
Preclinical Models of Meningioma, High recurrence rates and lack of effective systemic therapies contribute to the unfavorable prognosis of these patients. Accurate in vitro and in vivo models are critical for understanding meningioma pathogenesis and to identify and test novel therapeutics. In this chapter, we review cell models, 作者: extinct 時間: 2025-3-24 03:52 作者: Infant 時間: 2025-3-24 08:29
Immunotherapy for Meningiomas,rapy. Classical chemotherapy or anti-angiogenic agents exert only very limited activity in these tumors. Long-term survival of patients with advanced metastatic cancer following treatment with immune checkpoint inhibitors, i.e., monoclonal antibodies designed to unleash suppressed anticancer immune 作者: 悄悄移動 時間: 2025-3-24 14:28
Health-Related Quality of Life in Intracranial Meningioma: Current Evidence and Future Directions,atment on health-related quality of life (HRQoL). However, in the last decade there has been?increasing evidence that patients with intracranial meningiomas suffer from long-term decreases in their HRQoL. Compared with controls and normative data, meningioma patients have worse HRQoL scores both bef作者: institute 時間: 2025-3-24 18:31
Biological and Clinical Landscape of Meningiomas978-3-031-29750-2Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: Desert 時間: 2025-3-24 22:44
https://doi.org/10.1007/978-3-031-29750-2meningioma; central nervous system tumors; genomic landscape of meningioma; epigenomic landscape of men作者: 畢業(yè)典禮 時間: 2025-3-25 03:13 作者: Benzodiazepines 時間: 2025-3-25 03:48 作者: mortgage 時間: 2025-3-25 08:56 作者: 低能兒 時間: 2025-3-25 14:45 作者: 墻壁 時間: 2025-3-25 17:18
https://doi.org/10.1007/978-3-7091-8918-4es are frequently used in nearly all clinical settings where meningiomas are treated for the routine diagnosis and follow-up of these tumors, advances in neuroimaging have provided novel opportunities for prognostication and treatment planning (including both surgical planning and radiotherapy plann作者: 瑣碎 時間: 2025-3-25 20:08 作者: 有組織 時間: 2025-3-26 02:25 作者: 懦夫 時間: 2025-3-26 06:40
Oden und andere lyrische Formenywhere along the spinal column and their diagnosis is often delayed due to their slow growth and the lack of significant neurological symptoms until they reach a critical size, at which point signs of spinal cord or nerve root compression generally manifest and progress. If left untreated, spinal me作者: orient 時間: 2025-3-26 11:16
https://doi.org/10.1007/978-3-476-05355-8perated on are non-skull base tumors located in the parasagittal/parafalcine region and convexity, and more rarely along the tentorium, and in an intraventricular?location. These tumors present their own unique set of challenges given their unique anatomy and tend to be more biologically aggressive 作者: Disk199 時間: 2025-3-26 16:38 作者: 政府 時間: 2025-3-26 20:05
Klopstock/Milton - Teleskopie der Modernelace as first-line therapy for select meningioma?cases, particularly small meningiomas in challenging or high-risk anatomic locations. Radiosurgery for specific groups of meningiomas have been found to provide local control rates comparable to surgery alone. In this chapter stereotactic techniques f作者: ensemble 時間: 2025-3-26 22:31
Klopstock/Milton - Teleskopie der Moderner, the molecular era of medicine has resulted in new diagnostic paradigms anchored in the intrinsic biology of disease. The 2021 World Health Organization (WHO) reformulated the classification of CNS tumors to incorporate molecular parameters, in addition to histology, to define many tumor types. A 作者: chondromalacia 時間: 2025-3-27 02:35 作者: –LOUS 時間: 2025-3-27 08:14
Klopstock/Milton - Teleskopie der ModerneSources of this radiation exposure may be due to treatment of other cancers such as acute childhood leukemia, other central nervous system tumors such as medulloblastoma, the treatment of tinea capitis?(rarely and historically), or environmental exposures, as seen in some of the Hiroshima and Nagasa作者: Exaggerate 時間: 2025-3-27 11:31
Klopstock/Milton - Teleskopie der Moderneas meningiomas in the absence of any gene mutations and alter gene expression without affecting the sequence of the DNA itself. Some examples of these alterations that have been studied in meningiomas include DNA methylation, microRNA interaction, histone packaging, and chromatin restructuring. In t作者: CROAK 時間: 2025-3-27 14:19
https://doi.org/10.1007/978-3-476-99339-7sive and refractory to the current standards of care treatment?modalities. Coinciding with this has been increasing recognition of the important?that the immune system plays in mediating tumor growth and response to therapy. To address this point, immunotherapy has been leveraged for several other c作者: parallelism 時間: 2025-3-27 17:58
https://doi.org/10.1007/978-3-476-99339-7 High recurrence rates and lack of effective systemic therapies contribute to the unfavorable prognosis of these patients. Accurate in vitro and in vivo models are critical for understanding meningioma pathogenesis and to identify and test novel therapeutics. In this chapter, we review cell models, 作者: Maximize 時間: 2025-3-27 22:56
https://doi.org/10.1007/978-3-476-03842-5nts with inoperable, recurrent or high-grade tumors, medical therapy is often needed. Traditional chemotherapy and hormone therapy have been largely ineffective. However, with improved understanding of the molecular drivers in meningioma, there has been increasing interest in targeted molecular and 作者: recession 時間: 2025-3-28 03:07
,Nachwort von J?rg-Ulrich Fechner,rapy. Classical chemotherapy or anti-angiogenic agents exert only very limited activity in these tumors. Long-term survival of patients with advanced metastatic cancer following treatment with immune checkpoint inhibitors, i.e., monoclonal antibodies designed to unleash suppressed anticancer immune 作者: 移植 時間: 2025-3-28 06:18
,Nachwort von J?rg-Ulrich Fechner,atment on health-related quality of life (HRQoL). However, in the last decade there has been?increasing evidence that patients with intracranial meningiomas suffer from long-term decreases in their HRQoL. Compared with controls and normative data, meningioma patients have worse HRQoL scores both bef作者: Expertise 時間: 2025-3-28 12:17
Imaging Characteristics of Meningiomas,ing). These include perfusion MRIs, and positron emission tomography (PET) imaging modalities. Here we will summarize the contemporary uses for neuroimaging in meningiomas, and future applications of novel, cutting edge imaging techniques that may be routinely implemented in the future to enable more precise treatment of these challenging tumors.作者: Alveoli 時間: 2025-3-28 18:30
Histopathology of Meningiomas,s. We review the characteristic histological features of these meningioma variants, describe immunohistochemical stains, which may assist with establishing a diagnosis, and discuss differential diagnostic considerations that may prove challenging for a diagnosis of meningioma.作者: Ancestor 時間: 2025-3-28 21:50 作者: 無孔 時間: 2025-3-29 01:30 作者: 樂章 時間: 2025-3-29 06:55 作者: sclera 時間: 2025-3-29 10:18 作者: Distribution 時間: 2025-3-29 11:34
Preclinical Models of Meningioma,genetically engineered mouse models, and xenograft mouse models, with special emphasis on the field of application. Finally, promising preclinical 3D models such as organotypic tumor slices and patient-derived tumor organoids are discussed.作者: 老人病學(xué) 時間: 2025-3-29 17:05 作者: ALOFT 時間: 2025-3-29 23:03 作者: ostensible 時間: 2025-3-30 01:56 作者: nocturnal 時間: 2025-3-30 07:02
0065-2598 neurosurgery, neuropathology, radiology, radiation-oncology.."Meningiomas are tumors that originate from the arachnoidal cap cells of the leptomeninges. With an incidence rate of 8.36 per 100, 000 population, they are the most common primary central nervous system (CNS) tumors, accounting for a thir作者: 我要威脅 時間: 2025-3-30 09:14
Klopstock/Milton - Teleskopie der Moderne alterations that have been studied in meningiomas include DNA methylation, microRNA interaction, histone packaging, and chromatin restructuring. In this chapter we will describe in detail each of these mechanisms of epigenetic modification in meningiomas and their prognostic significance.作者: companion 時間: 2025-3-30 14:15 作者: intercede 時間: 2025-3-30 16:48
The Epigenetic Landscape of Meningiomas, alterations that have been studied in meningiomas include DNA methylation, microRNA interaction, histone packaging, and chromatin restructuring. In this chapter we will describe in detail each of these mechanisms of epigenetic modification in meningiomas and their prognostic significance.作者: Cumulus 時間: 2025-3-30 21:58 作者: ANT 時間: 2025-3-31 03:51
https://doi.org/10.1007/978-3-7091-8918-4ing). These include perfusion MRIs, and positron emission tomography (PET) imaging modalities. Here we will summarize the contemporary uses for neuroimaging in meningiomas, and future applications of novel, cutting edge imaging techniques that may be routinely implemented in the future to enable more precise treatment of these challenging tumors.作者: DEAF 時間: 2025-3-31 07:27
https://doi.org/10.1007/978-3-7091-8918-4s. We review the characteristic histological features of these meningioma variants, describe immunohistochemical stains, which may assist with establishing a diagnosis, and discuss differential diagnostic considerations that may prove challenging for a diagnosis of meningioma.